Employees: 75
Size Shoulder Innovations (SI) is a United States Health Care company (Medical Specialties) with a market value of $432M, the 2783rd largest of 3,085 United States companies the cockpit tracks. Shares closed at $20.65 on 18 Nov 2026.
Performance Over six months the shares gained 38.8%, against -21.1% for the median peer and -2.2% for the United States market (cap-weighted) — 2nd highest of 21 in its peer set.
Growth Revenue grew 54.9% over the last twelve months (peer median +1.4%); the operating margin is -54.4% (peer median 6.1%).
Valuation It trades at 5.5× enterprise value to sales against a peer median of 3.9× (6th most expensive of 19).
Capital Return on invested capital runs 74.2 points below its cost of capital (6.5% WACC).
Short interest Short interest is 3.4% of the free float (30 Oct 2026).
Next results Next results expected around 16 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | |
|---|---|---|---|---|
| Revenue | $64.5M | $47.3M | $31.6M | $19.3M |
| Revenue growth | — | +50% | +64% | — |
| Gross profit | $45.8M | $33.0M | $22.1M | $13.6M |
| EBITDA | -$30.7M | -$23.1M | -$12.5M | -$9.22M |
| Net income | -$33.4M | -$40.4M | -$15.6M | -$12.7M |
| Free cash flow | -$43.2M | -$36.0M | -$18.2M | -$15.9M |
| Capital expenditure | $7.76M | $7.41M | $4.01M | $2.75M |
| Total debt | $14.9M | $15.0M | $14.7M | $14.5M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | SI | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +10.3% | -9.6% | 3rd highest of 21 |
| 6-month return | +38.8% | -21.1% | 2nd highest of 21 |
| Distance from 52-week high | -16.0% | -44.8% | 2nd highest of 21 |
| Revenue growth (TTM) | +54.9% | +1.4% | 3rd highest of 20 |
| Operating margin | -54.4% | 6.1% | 4th lowest of 20 |
| EV / Sales | 5.5× | 3.9× | 6th most expensive of 19 |
| ROIC minus cost of capital | -74.2 pp | -2.2 pp | lowest of 17 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Shoulder Innovations SI | United States | $432M | +39% | +55% | -54% | 5.5× | n/a | n/a |
| Mobia Medical MOBI | United States | $434M | +2% | +105% | -145% | 8.8× | n/a | n/a |
| Revenio REG1V.HE | Finland | $428M | -34% | +44% | 10% | 4.0× | 18.5% | +12.4% |
| Guangzhou Jet Bio-Filtration 688026.SS | China | $436M | +39% | +5% | 11% | 4.8× | 20.6% | +2.2% |
| China Isotope & Radiation 1763.HK | Hong Kong | $428M | -41% | -5% | 13% | n/a | n/a | n/a |
| Hunan Sundy Science and Technology 300515.SZ | China | $425M | -16% | +10% | 27% | 3.5× | -0.1% | +15.6% |
| Huaren Pharmaceutical 300110.SZ | China | $440M | -16% | -3% | 6% | 3.3× | 5.8% | +0.3% |
| Clarity Pharmaceuticals CU6.AX | Australia | $444M | -33% | n/a | n/a | n/a | n/a | n/a |
| Ningbo Tianyi Medical Appliance 301097.SZ | China | $418M | -22% | +46% | 8% | 4.4× | n/a | n/a |
| Jenscare Scientific 9877.HK | Hong Kong | $415M | -32% | +993% | -106% | 17.8× | n/a | n/a |
| Shanghai Kindly Enterprises Development 603987.SS | China | $452M | -12% | 0% | 10% | 1.5× | -1.0% | -2.8% |
| Guangdong Shirongzhaoye 002016.SZ | China | $453M | -26% | -31% | 3% | 3.8× | 21.5% | -11.7% |
| PROTEINA 468530.KS | South Korea | $460M | +5% | -59% | -1,178% | 410.3× | n/a | n/a |
| Beijing Leadman Biochemistry 300289.SZ | China | $460M | -9% | +46% | 1% | 8.2× | 36.0% | -6.9% |
| Chison Medical Technologies 688358.SS | China | $406M | -27% | -1% | 19% | 3.9× | 9.6% | +5.6% |
| Shanghai Titan Scientific 688133.SS | China | $403M | -26% | +1% | -6% | 1.4× | n/a | n/a |
| MiMedx MDXG | United States | $464M | -16% | -23% | -8% | 1.1× | 10.9% | +11.0% |
| Eiken Chemical 4549.T | Japan | $466M | -20% | +4% | 6% | 1.6× | n/a | n/a |
| Guanhao Biotech 300238.SZ | China | $397M | -26% | -12% | 3% | 7.1× | n/a | n/a |
| 908 Devices MASS | United States | $396M | +36% | +14% | -33% | 4.6× | 41.7% | +15.9% |
| WELL LEAD MEDICAL 603309.SS | China | $473M | -22% | +1% | 15% | 2.0× | -5.9% | +7.7% |